Dicer1 functions as a haploinsufficient tumor suppressor - PubMed (original) (raw)

Dicer1 functions as a haploinsufficient tumor suppressor

Madhu S Kumar et al. Genes Dev. 2009.

Abstract

While the global down-regulation of microRNAs (miRNAs) is a common feature of human tumors, its genetic basis is largely undefined. To explore this question, we analyzed the consequences of conditional Dicer1 mutation (Dicer1 "floxed" or Dicer1(fl)) on several mouse models of cancer. Here we show Dicer1 functions as a haploinsufficient tumor suppressor gene. Deletion of a single copy of Dicer1 in tumors from Dicer1(fl/+) animals led to reduced survival compared with controls. These tumors exhibited impaired miRNA processing but failed to lose the wild-type Dicer1 allele. Moreover, tumors from Dicer1(fl/fl) animals always maintained one functional Dicer1 allele. Consistent with selection against full loss of Dicer1 expression, enforced Dicer1 deletion caused inhibition of tumorigenesis. Analysis of human cancer genome copy number data reveals frequent deletion of DICER1. Importantly, however, the gene has not been reported to undergo homozygous deletion, suggesting that DICER1 is haploinsufficient in human cancer. These findings suggest Dicer1 may be an important haploinsufficient tumor suppressor gene and, furthermore, that other factors controlling miRNA biogenesis may also function in this manner.

PubMed Disclaimer

Figures

Figure 1.

Figure 1.

Dicer1 mutation reduces post-infection survival in a genetically engineered mouse model of K-Rasdriven lung cancer. KrasLSL-G12D mice, either wild type or heterozygous or homozygous conditional for Dicer1 (KD+/+, KDfl/+, and KDfl/fl, respectively), were intranasally infected with Ad-Cre, and survival was assessed. Median survival was 194 d for KD+/+ mice, 108 d for KDfl/+ mice, and 143 d for KDfl/fl mice. Statistical significance was assessed by the log-rank test.

Figure 2.

Figure 2.

Dicer1 undergoes hemizygous loss in lung tumors. (A) DNA was prepared from KrasLSL-G12D mouse embryonic fibroblasts (MEFs) either heterozygous conditional or mutant for Dicer1 (KDfl/+ and KD+/−) and lung cancer cell lines from KPDfl/+ mice, and the Dicer1 locus was examined by PCR. (B) DNA was prepared from KrasLSL-G12D mouse embryonic fibroblasts either homozygous conditional or heterozygous mutant for Dicer1 (KDfl/fl and KD+/−) and lung cancer cell lines from KPDfl/fl mice, and the Dicer1 locus was examined by PCR.

Figure 3.

Figure 3.

Hemizygous deletion of Dicer1 causes a global reduction in steady-state miRNA levels. (A) miRNA profiling and hierarchical clustering were performed on lung cancer cell lines either wild type (KPD+/+) or heterozygous for Dicer1 (KPD+/− and KPDfl/−). (B) Small RNA Northern blotting analysis of miRNAs and glutamine tRNA was performed on lung cancer cell lines wild type or heterozygous for Dicer1 as above.

Figure 4.

Figure 4.

Complete deletion of Dicer1 inhibits sarcoma development. (A) KPDfl/+ and KPDfl/− sarcoma cell lines were infected with MSCV.CreERT2.puro. Cre-mediated recombination was induced by treatment with 4-OHT for defined time points. DNA was prepared, and recombination of the Dicer1 locus was assessed by PCR. (B) Two independent KPDfl/− sarcoma cell lines infected with MSCV.CreERT2.puro were injected subcutaneously into C57Bl6/129SV F1 animals. Animals were treated with or without tamoxifen by intraperitoneal injection, and tumor growth was measured over time. Values are mean ± SEM (n = 8 each). (C) Tumors were isolated from KPDfl/− sarcoma cell line transplants treated with or without tamoxifen. DNA was prepared, and recombination of the Dicer1 locus was assessed by PCR. Asterisk corresponds to the wild-type Dicer1 locus from the C57Bl6/129SV F1 host animals.

Comment in

Similar articles

Cited by

References

    1. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297. - PubMed
    1. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ, Mills AA, Elledge SJ, Anderson KV, Hannon GJ. Dicer is essential for mouse development. Nat Genet. 2003;35:215–217. - PubMed
    1. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2008;40:43–50. - PMC - PubMed
    1. Chang TC, Zeitels LR, Hwang HW, Chivukula RR, Wentzel EA, Dews M, Jung J, Gao P, Dang CV, Beer MA, et al. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc Natl Acad Sci. 2009;106:3384–3389. - PMC - PubMed
    1. Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A, Ford L, Weidhaas JB, Brown D, Bader AG, Slack FJ. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle. 2008;7:759–764. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources